Hepatitis C Education for Pregnant Women With Opiate Addiction - Phase 1

Hepatitis C Clinical Trial

Official title:

Hepatitis C Education for Pregnant Women With Opiate Addiction - Phase 1

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03245931
• Other study ID #: 17007
• Status: Completed
• Start date: July 20, 2017
• Est. completion date: August 26, 2019

Study information

• Verified date: August 2019
• Source: TriHealth Inc.
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The goal of this study is to assess the health literacy level of patients enrolled in the HOPE program, identify any gaps in their knowledge of hepatitis C, analyze the variables that may influence patients' knowledge, and educate patients on Hepatitis C.

Description:

The study will compare the effectiveness of providing a pamphlet and expert education compared to providing a pamphlet only. The information gained in completing this study will help the medical community improve patient education on the disease and specifically understand how the medical community can best serve pregnant patients with opiate dependence burdened by Hepatitis C.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 8
• Est. completion date: August 26, 2019
• Est. primary completion date: August 26, 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 18 Years and older

Eligibility

Inclusion Criteria

• The study will include patients with and without Hepatitis C diagnosis.

• Patients will be recruited at their routine prenatal and post-partum visits.

• Patients who speak and understand English

Exclusion Criteria:

• Patients under the age of the 18 years

Related Conditions & MeSH terms

• Hepatitis
• Hepatitis A
• Hepatitis C
• Opioid-Related Disorders

Intervention

Other:
• Qualitative Interview
Complete 6 open-ended qualitative questions on patients in the HOPE program to assess basic current understanding about Hepatitis C and topics of interest that patients in the HOPE program would like to learn more about.

Locations

Country	Name	City	State
United States	Good Samaritan Hospital	Cincinnati	Ohio

Sponsors (1)

Lead Sponsor	Collaborator
TriHealth Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Discovering the gaps in patients' knowledge of Hepatitis C	Through interview, 6 open-ended qualitative questions will be asked of the patients in the HOPE program to assess basic current understanding about Hepatitis C	2 months